BioSpace News Archive

Alercell announced that it has reached an agreement for distribution of COVID-19 rapid antibody serology tests with manufacturer Medigen Biotechnology Corp, a publicly traded company-controlling shareholder of TBG Biotechnology Corp.

7D Surgical announced today that it has received approval from the Health Sciences Authority (HSA) in Singapore for its innovative Machine-vision Image Guidance System (MvIGS) for spinal navigation. In addition, 7D Surgical has already completed its first system sale through its distribution partnership with Transmedic, a premier medical t

Houston Methodist Research Institute Professor and Chair of the Department of Cardiovascular Sciences Dr. John Cooke and LSU Health Shreveport Vice Chancellor Dr. Alan Kaye Join the JanOne Team

Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety and transparency of cannabis, today announced that SD PharmLabs, a multistate testing lab organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Texas hemp lab, the first in that state.

resTORbio, Inc., a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, provided a corporate update and reported financial results for the second quarter ended June 30, 2020.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, announced today that its second quarter 2020 financial results will be released after the market closes on Thursday, August 6, 2020. Following the release, t

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has filed a Marketing Authorisation Application (MAA) with the European Medicines Agency (EMA) for oral tecovirimat, the same formulation that was approved by the U.S. Food and Drug Administration (FDA) in July 2018 under the name TPOXX®.

Reports record quarterly revenue of $87.5 million Overall revenue grew 24% year-over-year, with organic growth of 19% Raises revenue guidance to $332-$340 million for full year 2020, representing 18%-21% organic growth Completes acquisition of silicone molding and tubing manufacturer Engineered Molding Technology WALTHAM, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today repor

Savonix, a global leader in digital cognitive health testing, and Japanese trading company Mitani Sangyo Co, Ltd, announced yesterday a strategic partnership to provide Savonix’s digital cognitive assessment to all its employees over the age of 40

Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable October 30, 2020 to shareholders of record at the close of business on September 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.